CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195 | -99.0% | 116 | -98.4% | 0.00% | – |
| Q2 2023 | $20,410 | -71.5% | 7,212 | -50.6% | 0.00% | – |
| Q1 2023 | $71,664 | -98.7% | 14,596 | -96.8% | 0.00% | -100.0% |
| Q1 2022 | $5,578,000 | +27.8% | 459,100 | +28.1% | 0.02% | +29.4% |
| Q4 2021 | $4,364,000 | +225.7% | 358,300 | +330.6% | 0.02% | +142.9% |
| Q4 2019 | $1,340,000 | -51.8% | 83,200 | -45.3% | 0.01% | -58.8% |
| Q3 2019 | $2,780,000 | +55.1% | 152,096 | +66.5% | 0.02% | +112.5% |
| Q1 2019 | $1,792,000 | +132.7% | 91,324 | +82.6% | 0.01% | +100.0% |
| Q2 2017 | $770,000 | -16.3% | 50,000 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $920,000 | -89.7% | 50,000 | -90.6% | 0.01% | -93.2% |
| Q4 2015 | $8,939,000 | +2425.1% | 530,200 | +2037.9% | 0.07% | +2366.7% |
| Q3 2015 | $354,000 | -41.6% | 24,800 | -50.3% | 0.00% | -25.0% |
| Q2 2015 | $606,000 | – | 49,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |